GemOx regimen

	WikiDoc Resources for GemOx regimen
Articles
Most recent articles on GemOx regimen Most cited articles on GemOx regimen Review articles on GemOx regimen Articles on GemOx regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on GemOx regimen Images of GemOx regimen Photos of GemOx regimen Podcasts & MP3s on GemOx regimen Videos on GemOx regimen
Evidence Based Medicine
Cochrane Collaboration on GemOx regimen Bandolier on GemOx regimen TRIP on GemOx regimen
Clinical Trials
Ongoing Trials on GemOx regimen at Clinical Trials.gov Trial results on GemOx regimen Clinical Trials on GemOx regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on GemOx regimen NICE Guidance on GemOx regimen NHS PRODIGY Guidance FDA on GemOx regimen CDC on GemOx regimen
Books
Books on GemOx regimen
News
GemOx regimen in the news Be alerted to news on GemOx regimen News trends on GemOx regimen
Commentary
Blogs on GemOx regimen
Definitions
Definitions of GemOx regimen
Patient Resources / Community
Patient resources on GemOx regimen Discussion groups on GemOx regimen Patient Handouts on GemOx regimen Directions to Hospitals Treating GemOx regimen Risk calculators and risk factors for GemOx regimen
Healthcare Provider Resources
Symptoms of GemOx regimen Causes & Risk Factors for GemOx regimen Diagnostic studies for GemOx regimen Treatment of GemOx regimen
Continuing Medical Education (CME)
CME Programs on GemOx regimen
International
GemOx regimen en Espanol GemOx regimen en Francais
Business
GemOx regimen in the Marketplace Patents on GemOx regimen
Experimental / Informatics
List of terms related to GemOx regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:GEM-OX Regimen; Gemcitabine-Oxaliplatin Regimen; GEMOX Regimen

Overview

GemOx regimen refers to a regimen consisting of gemcitabine and oxaliplatin used for the treatment of biliary adenocarcinoma, pancreatic cancer, hepatocellular cancer^[1] and testicular cancer^[2]. This regimen is currently being studied in a variety of other cancers.

Regimen

GemGemcitabine

OxOxaliplatin

Indications

References

↑ ^1.0 ^1.1 Patrikidou A, Sinapi I, Regnault H, Fayard F, Bouattour M, Fartoux L; et al. (2014). "Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies". Invest New Drugs. 32 (5): 1028–35. doi:10.1007/s10637-014-0100-y. PMID 24748335.
↑ ^2.0 ^2.1 Pectasides D, Pectasides M, Farmakis D, Aravantinos G, Nikolaou M, Koumpou M; et al. (2004). "Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study". Ann Oncol. 15 (3): 493–7. PMID 14998855.

[pmid24748335-1] 1.0 ^1.1 Patrikidou A, Sinapi I, Regnault H, Fayard F, Bouattour M, Fartoux L; et al. (2014). "Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies". Invest New Drugs. 32 (5): 1028–35. doi:10.1007/s10637-014-0100-y. PMID 24748335.

[pmid14998855-2] 2.0 ^2.1 Pectasides D, Pectasides M, Farmakis D, Aravantinos G, Nikolaou M, Koumpou M; et al. (2004). "Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study". Ann Oncol. 15 (3): 493–7. PMID 14998855.

[1]

[2]

GemOx regimen

Overview

Regimen

Indications

References

Navigation menu